This commentary will appear in the August issue of Evidence-Based Oncology.
John Schuler, MD
Advertisement
John Schuler, MD, is a radiation oncologist at Compass Oncology.
Articles by John Schuler, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Lutetium Lu 177 for Earlier-Stage Prostate Cancer
2
Expanding Community Access to CAR T, Bispecific Therapies in Multiple Myeloma: Peter Forsberg, MD
3
Atacicept Becomes First BAFF/APRIL Inhibitor Approved for IgA Nephropathy: Richard Lafayette, MD
4
Philadelphia Employer Coalition Podcast Targets GLP-1s, Cancer Care
5